Company intelligence / Profile preview

RICBT

Ownership
Private
Development stage
Commercial
01

Overview

RIC biologics is a European center of excellence providing comprehensive analytical solutions for pharmaceutical and biotechnology companies. The company specializes in supporting the development of biological products and chemical entities through advanced analytics, including characterization, quantification, stability testing, comparability studies, formulation support, dossier preparation for regulatory submissions, and more. Their expertise covers a wide range of modalities such as monoclonal antibodies (including biobetters and biosimilars), ADCs, bispecifics/multispecifics, fusion proteins, enzymes/peptides/oligonucleotides/DNA/RNA/small molecules/cell-based products/vaccines[1][2].

Modalities
Monoclonal antibodyAntibody fragmentAntibody-drug conjugateBispecific monoclonal antibodyMulti-specific antibodyFusion proteinEnzyme replacement therapy (Enzyme)PeptidesOligonucleotide (DNA, RNA)Small moleculeCell therapy product (Cell-based products)Vaccine (including complex formulations)
Industry
Drug Discovery Services

Beyond the preview

Go deeper on RICBT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RICBT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call